Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-15 · accession 0001871002-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-08-18 | 2025-08-15 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $86.97 | -20.0K | 173.2K | -10% | -$1.74M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | S | D | 20,000 | $86.97 | 173,226 | I Held by Chali Properties LLC | — | — | (F1) The shares were sold in multiple trades at prices ranging from $86.54 to $88.05. The price reported above reflects the weighted average sales price. (F2) The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. |